Epidemiological studies show that maternal immune activation (MIA) during pregnancy is a risk factor for autism. However, mechanisms for how MIA affects brain development and behaviors in offspring remain poorly described. To determine whether placental interleukin-6 (IL-6) signaling is required for mediating MIA on the offspring, we generated mice with restricted deletion of the receptor for IL-6 (IL-6Ra) in placental trophoblasts (Cyp19-Cre 
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Introduction
Autism spectrum disorder (ASD) is a range of complex neurodevelopmental disorders, characterized by difficulties in social communication, and repetitive and stereotyped behaviors (Association, 2013) . To date, the prevalence for ASD in the United States is one in 68 children (Investigators, 2014) and diagnoses worldwide are 62 per 10,000 people (Elsabbagh et al., 2012) . Monozygotic twins studies indicate the concordance rate for ASD ranges between 60 and 91% (Ronald and Hoekstra, 2011), which suggests both genetic and non-genetic factors (e.g. environment) could contribute to the etiology of ASD.
Epidemiological studies suggest that maternal infection is a principal non-genetic risk factor for ASD (Brown, 2012) . Analyses of large cohorts of ASD patients found that inpatient diagnosis of severe infection during pregnancy are associated with increased ASD risk (Atladottir et al., 2010; Lee et al., 2014) . The diversity of infections and the observation that many are not transmitted to the fetus (Fatemi et al., 2012; Shi et al., 2005) suggest that maternal immune activation (MIA), rather than microbial pathogenesis, is responsible for increasing the risk of ASD in the offspring. This emphasis on MIA rather than a specific pathogen is supported by animal models that involve injection of non-pathogenic antigens, such as polyinosinic-polycytidylic acid (poly(I:C)) (Boksa, 2010; Meyer, 2014) . Stimulation of the maternal immune system in these cases causes offspring to develop behavioral and neuropathological features of ASD similar to those seen in maternal infection (Boksa, 2010; Knuesel et al., 2014; Meyer, 2014) .
The molecular mechanisms underlying abnormal neurodevelopment and behavior in MIA are poorly understood, though cytokines appear to be critical (Boksa, 2010; Knuesel et al., 2014) . The immune dysregulation in MIA offspring persists postnatally (Garay et al., 2013; Hsiao et al., 2012) . MIA causes long-lasting and region specific changes of brain cytokines in the offspring that vary based on developmental time point (Garay et al., 2013) . Furthermore, MIA leads to decreases in splenic and mesenteric regulatory T cells (Tregs) and increases in interleukin (IL)-6 and IL-17 production in splenic CD4 + T cells in adult offspring (Hsiao et al., 2012) . IL-6 levels are elevated in fetal brain after MIA induction (Connor et al., 2012; Meyer et al., 2006; Wu et al., 2015) . Blocking IL-6, but not IL-1b or interferon gamma (IFNc), after induction of MIA in pregnant mice prevents behavioral abnormalities in the offspring (Smith et al., 2007 
